Reckitt Benckiser Rises to Record as Sales Beat Estimates

Reckitt Benckiser Group Plc rose to a record in London trading after the maker of Nurofen posted revenue that beat estimates, defying a slowdown that has hurt competitors, boosted by increased sales of health-related products and a turnaround in developed markets.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.